2221. Active Substance Use Should Not Be a Contraindication for Hepatitis C Treatment in Hepatitis C and Human Immunodeficiency Virus Co-infected Patients

BACKGROUND: Hepatitis C virus (HCV) infection disproportionately affects HIV-infected patients. HIV/HCV Co-infected patients are more likely to develop advanced liver disease/cirrhosis in comparison to mono-infected patients. HCV treatment with new oral direct-acting antiviral (DAA) therapy is effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeineddine, Nabil, Coppock, Dagan, Szep, Zsofia, Scott, Tiffany, Franks, Taneesa, Kesaris, Anna, Chou, Edgar, Lee, Dong Heun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252566/
http://dx.doi.org/10.1093/ofid/ofy210.1874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252566/
http://dx.doi.org/10.1093/ofid/ofy210.1874

Ejemplares similares